Concepedia

Rishav Adhikari

RA

4

Publications

189

Citations

4

H-Index

2022

Active since

Affiliations

Johns Hopkins University(Current)

Houston Methodist

Rishav Adhikari is an author at Johns Hopkins University specializing in cardiovascular disease, cardiology, and health policy.

Top concepts

MedicineCardiologyHealth PolicyPublic HealthCardiovascular DiseaseDiabetesThrombosisEpidemiologyHypertensionPharmacology

Publications per year

2022–2024

4

Publications

4

National Trends in Use of Sodium‐Glucose Cotransporter‐2 Inhibitors and Glucagon‐like Peptide‐1 Receptor Agonists by Cardiologists and Other Specialties, 2015 to 2020

Rishav Adhikari, Kunal Jha, Zeina Dardari et al. · Journal of the American Heart Association · 2022 · 139 citations · Full text

Cardiovascular Pharmacology, Peptide Therapeutics, Pharmacotherapy +24

Online searches for SGLT-2 inhibitors and GLP-1 receptor agonists correlate with prescription rates in the United States: An infodemiological study

Omar Dzaye, Philipp Berning, Alexander C. Razavi et al. · Frontiers in Cardiovascular Medicine · 2022 · 24 citations · Full text

Coronary artery calcium in 2023: Guidelines for LDL-C goals, non-statin therapies, and aspirin use

Garshasb Soroosh, Erfan Tasdighi, Rishav Adhikari et al. · Progress in Cardiovascular Diseases · 2024 · 14 citations

Thrombosis, Hypertension, Vascular Disease +14

Cardiovascular risk stratification among individuals with obesity: The Coronary Artery Calcium Consortium

Ellen Boakye, Gowtham R. Grandhi, Zeina Dardari et al. · Obesity · 2023 · 12 citations · Full text

Rows per page

1–4 of 4